János Szőke

<i>MET</i> amplification occurs with or without <i>T790M</i> mutations in <i>EGFR</i> mutant lung tumors with acquired resistance to gefitinib or erlotinib

James Bean, Cameron Brennan, Jin‐Yuan Shih et al. · Proceedings of the National Academy of Sciences · 2007 · 1.6K citations

Medicine, Genetics, Oncology +17

Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis

Noriko Motoi, János Szőke, Gregory J. Riely et al. · The American Journal of Surgical Pathology · 2008 · 373 citations

Medicine, Oncology, Pathology +17

An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors

Dhananjay Chitale, Yongxing Gong, Barry S. Taylor et al. · Oncogene · 2009 · 232 citations · Full text

Medicine, Genetics, Oncology +14

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

James Bean, Cameron Brennan, Jin-Yuan Shih et al. · Molecular Cancer Therapeutics · 2007 · 121 citations

Medicine, Molecular Genetics, Oncology +17

Identification of DOK genes as lung tumor suppressors

Alice H. Berger, Masaru Niki, Alessandro Morotti et al. · Nature Genetics · 2010 · 116 citations · Full text

Life Sciences, Genetics, Molecular Biology +11